Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis

Keyphrases

• Adverse Events 100%
• Orlistat 100%
• Document Analysis 100%
• Clinical Report 100%
• Placebo Groups 11%
• Placebo 5%
• Randomized Placebo-controlled Trial 5%
• New Drugs 5%
• PubMed 5%
• Serious Adverse Events 5%
• European Medicines Agency 5%
• Mid-1990s 5%
• Adverse Event Reporting 5%
• Gastrointestinal Side Effects 5%
• Multiple Episodes 5%
• Adverse Event Data 5%
• Marketing Authorization 5%
• Freedom of Information 5%
• Slimming 5%
• Extracted Data 5%
• Fasting Blood Glucose 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 100%
• Clinical Study 100%
• Tetrahydrolipstatin 100%
• Placebo 19%
• Glucose 4%